Singapore group buys Morrisville office portfolio in $189 million deal
Date Published:
A Triangle office portfolio changed hands last week when a Singapore-based investment firm spent over $189 million on the properties…
Home Page
Duke researchers seek FDA approval for solution to split ventilators between patients
Date Published:
DURHAM – Researchers at Duke University have engineered a workaround to make ventilators safer and more efficient when splitting them…
Novartis Gene Therapies is new name for gene therapy firm with growing RTP presence
Date Published:
RESEARCH TRIANGLE PARK – Don’t call it AveXis anymore. It’s now Novartis Gene Therapies.
Novartis has announced the renaming of…
SAS ranks as one of People magazine’s ‘Companies That Care’
Date Published:
CARY — SAS has ranked on People magazine’s fourth annual 50 Companies That Care list.
The Cary-based software analytics firm…
Gene therapy company bluebird bio reports positive test results for treatment
Date Published:
RESEARCH TRIANGLE PARK – bluebird bio, a global gene therapy company with a new manufacturing facility in Durham, has unveiled…
Triangle therapeutics startup’s deal with global firm RTI is important – here’s why
Date Published:
RESEARCH TRIANGLE PARK – A newly established high-powered Research Triangle Park company, APIE Therapeutics, has signed a licensing agreement with …
Durham’s BioCryst lands $44M contract to test anti-viral drug against COVID-19 virus
Date Published:
RESEARCH TRIANGLE PARK — BioCryst Pharmaceuticals has landed a $44 million contract to see if its investigational anti-viral drug, galidesivir,…
9 investors provide Raleigh agtech startup with $444k; firm seeks $306K more
Date Published:
RALEIGH – Startup TerMir, which recently beat out 70 emerging agtech startups from around the country to win the inaugural …
Bill Gates, Alzheimer’s Association provide $740K grant to RTP startup
Date Published:
RESEARCH TRIANGLE PARK – T3D Therapeutics, a life science startup seeking to develop a treatment for Alzheimer’s disease, has another…